This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
[Retracted] miR-372 promotes breast cancer cell proliferation by directly targeting LATS2
Xueyuan Cheng, Junqiang Chen, Zhong Huang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research
Exp Ther Med 15:2812–2817, 2018; DOI: 10.3892/etm.2018.5761
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the flow cytometric data shown in Fig. 3C on p. 2815 were strikingly similar to data that had already appeared in different form in another article written by different authors at different research institutes, which had already been published in the journal OncoTarget. After having performed an independent analysis of the data in the Editorial Office, it came to light that certain of the colony-formation assay data (the ‘Control’ data) in Fig. 2C on p. 2814 were also included in an article submitted for publication to another journal at around the same time.
In view of the fact that the abovementioned data had already apparently been published previously, the Editor of Experimental and Therapeutic Medicine has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.